418 related articles for article (PubMed ID: 30685529)
1. Cancer treatment effects on cognition and depression: The moderating role of physical activity.
Bedillion MF; Ansell EB; Thomas GA
Breast; 2019 Apr; 44():73-80. PubMed ID: 30685529
[TBL] [Abstract][Full Text] [Related]
2. Potential factors associated with perceived cognitive impairment in breast cancer survivors.
Myers JS; Wick JA; Klemp J
Support Care Cancer; 2015 Nov; 23(11):3219-28. PubMed ID: 25832894
[TBL] [Abstract][Full Text] [Related]
3. Cognition, quality-of-life, and symptom clusters in breast cancer: Using Bayesian networks to elucidate complex relationships.
Xu S; Thompson W; Ancoli-Israel S; Liu L; Palmer B; Natarajan L
Psychooncology; 2018 Mar; 27(3):802-809. PubMed ID: 29055062
[TBL] [Abstract][Full Text] [Related]
4. Cognitive performance of breast cancer survivors in daily life: Role of fatigue and depressed mood.
Small BJ; Jim HSL; Eisel SL; Jacobsen PB; Scott SB
Psychooncology; 2019 Nov; 28(11):2174-2180. PubMed ID: 31418499
[TBL] [Abstract][Full Text] [Related]
5. Subjective cognitive functioning and associations with psychological distress in adult brain tumour survivors.
Nicol C; Ownsworth T; Cubis L; Nguyen W; Foote M; Pinkham MB
J Cancer Surviv; 2019 Oct; 13(5):653-662. PubMed ID: 31313128
[TBL] [Abstract][Full Text] [Related]
6. Perceived cognitive function in breast cancer survivors: evaluating relationships with objective cognitive performance and other symptoms using the functional assessment of cancer therapy-cognitive function instrument.
Von Ah D; Tallman EF
J Pain Symptom Manage; 2015 Apr; 49(4):697-706. PubMed ID: 25240787
[TBL] [Abstract][Full Text] [Related]
7. An Examination of the Longitudinal Relationship Between Cognitive Function and Physical Activity Among Older Breast Cancer Survivors in the Thinking and Living With Cancer Study.
Tometich DB; Mosher CE; Cyders M; McDonald BC; Saykin AJ; Small BJ; Zhai W; Zhou X; Jim HSL; Jacobsen P; Ahles TA; Root JC; Graham D; Patel SK; Mandelblatt J
Ann Behav Med; 2023 Apr; 57(3):237-248. PubMed ID: 36356044
[TBL] [Abstract][Full Text] [Related]
8. Cognitive problems of breast cancer survivors on proton pump inhibitors.
Madison AA; Woody A; Bailey B; Lustberg MB; Ramaswamy B; Wesolowski R; Williams N; Reinbolt R; VanDeusen JB; Sardesai S; Malarkey WB; Kiecolt-Glaser JK
J Cancer Surviv; 2020 Apr; 14(2):226-234. PubMed ID: 31933149
[TBL] [Abstract][Full Text] [Related]
9. Changes in light-, moderate-, and vigorous-intensity physical activity and changes in depressive symptoms in breast cancer survivors: a prospective observational study.
Sylvester BD; Ahmed R; Amireault S; Sabiston CM
Support Care Cancer; 2017 Nov; 25(11):3305-3312. PubMed ID: 28497387
[TBL] [Abstract][Full Text] [Related]
10. Adaptations to cognitive problems reported by breast cancer survivors seeking cognitive rehabilitation: A qualitative study.
Green HJ; Mihuta ME; Ownsworth T; Dhillon HM; Tefay M; Sanmugarajah J; Tuffaha HW; Ng SK; Shum DHK
Psychooncology; 2019 Oct; 28(10):2042-2048. PubMed ID: 31364225
[TBL] [Abstract][Full Text] [Related]
11. Relationship between self-reported and objectively measured physical activity and subjective memory impairment in breast cancer survivors: role of self-efficacy, fatigue and distress.
Phillips SM; Lloyd GR; Awick EA; McAuley E
Psychooncology; 2017 Sep; 26(9):1390-1399. PubMed ID: 27388973
[TBL] [Abstract][Full Text] [Related]
12. Perceived cognitive impairment in people with colorectal cancer who do and do not receive chemotherapy.
Dhillon HM; Tannock IF; Pond GR; Renton C; Rourke SB; Vardy JL
J Cancer Surviv; 2018 Apr; 12(2):178-185. PubMed ID: 29080061
[TBL] [Abstract][Full Text] [Related]
13. Evaluating cognitive complaints in breast cancer survivors with the FACT-Cog and quantitative electroencephalography.
Van Dyk K; Hunter AM; Ercoli L; Petersen L; Leuchter AF; Ganz PA
Breast Cancer Res Treat; 2017 Nov; 166(1):157-166. PubMed ID: 28707203
[TBL] [Abstract][Full Text] [Related]
14. Pretreatment Psychoneurological Symptoms and Their Association With Longitudinal Cognitive Function and Quality of Life in Older Breast Cancer Survivors.
Tometich DB; Small BJ; Carroll JE; Zhai W; Luta G; Zhou X; Kobayashi LC; Ahles T; Saykin AJ; Clapp JD; Jim HSL; Jacobsen PB; Hurria A; Graham D; McDonald BC; Denduluri N; Extermann M; Isaacs C; Dilawari A; Root J; Rini C; Mandelblatt JS;
J Pain Symptom Manage; 2019 Mar; 57(3):596-606. PubMed ID: 30472317
[TBL] [Abstract][Full Text] [Related]
15. Determinants of physical, affective, and cognitive fatigue during breast cancer therapy and 12 months follow-up.
Schmidt ME; Wiskemann J; Schneeweiss A; Potthoff K; Ulrich CM; Steindorf K
Int J Cancer; 2018 Mar; 142(6):1148-1157. PubMed ID: 29082588
[TBL] [Abstract][Full Text] [Related]
16. NeuroCog FX study: A multicenter cohort study on cognitive dysfunction in patients with early breast cancer.
Rick O; Reuß-Borst M; Dauelsberg T; Hass HG; König V; Caspari R; Götz-Keil G; Pfitzner J; Kerschgens C; Fliessbach K; Hoppe C
Psychooncology; 2018 Aug; 27(8):2016-2022. PubMed ID: 29771474
[TBL] [Abstract][Full Text] [Related]
17. Objective-subjective disparity in cancer-related cognitive impairment: does the use of change measures help reconcile the difference?
O'Farrell E; Smith A; Collins B
Psychooncology; 2017 Oct; 26(10):1667-1674. PubMed ID: 27278814
[TBL] [Abstract][Full Text] [Related]
18. Self-reported chemotherapy-related cognitive impairment compared with cognitive complaints following menopause.
Vega JN; Dumas J; Newhouse PA
Psychooncology; 2018 Sep; 27(9):2198-2205. PubMed ID: 29904964
[TBL] [Abstract][Full Text] [Related]
19. Cognitive limitations associated with tamoxifen and aromatase inhibitors in employed breast cancer survivors.
Breckenridge LM; Bruns GL; Todd BL; Feuerstein M
Psychooncology; 2012 Jan; 21(1):43-53. PubMed ID: 20967847
[TBL] [Abstract][Full Text] [Related]
20. A mechanistic cohort study evaluating cognitive impairment in women treated for breast cancer.
Vardy JL; Stouten-Kemperman MM; Pond G; Booth CM; Rourke SB; Dhillon HM; Dodd A; Crawley A; Tannock IF
Brain Imaging Behav; 2019 Feb; 13(1):15-26. PubMed ID: 28466438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
